Is Shanghai Bima Life Sciences a funded company?

Shanghai Bima Life Sciences is a funded company, having raised a total of $***** in its 1st and only funding round, a Angel round on Jan 19, 2024.

When was the latest funding round of Shanghai Bima Life Sciences?

Shanghai Bima Life Sciences' latest funding was a $***** Angel round on Jan 19, 2024, with participation from 0 investor.

Where does Shanghai Bima Life Sciences rank among its competitors?

Shanghai Bima Life Sciences ranks 3rd amongst 4 active competitors, of which 3 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Imperagen, which secured $6.71M in May, 2026.

Who are the top competitors of Shanghai Bima Life Sciences?

Shanghai Bima Life Sciences' top competitors include Imperagen, Anzen Industries and DirectBio. Among them, Imperagen secured the most recent funding round in May, 2026.

Shanghai Bima Life Sciences - 2026 Company Profile, Team, Funding & Competitors

Shanghai Bima Life Sciences is a seed company, founded by Wu Di. It operates as a Provider of proteomics detection platform based on antibody affinity assay. Shanghai Bima Life Sciences has raised an undisclosed amount in funding. The company has 4 active competitors, including 3 that are funded. Its top competitors are Imperagen, Anzen Industries and DirectBio.

Company Details

Provider of proteomics detection platform based on antibody affinity assay. The company has proprietary Proximity Barcoding Assay technology that uses a combination of protein molecule tags and RCA proximity tags for single-molecule protein quantification.

Key Metrics

Stage

Seed

Latest Funding Round

Angel, Jan 19, 2024, $*****

Ranked

3^rd among 4 active competitors

Similar Companies

Imperagen & 2 more

View Shanghai Bima Life Sciences' full profile

Shanghai Bima Life Sciences has raised funding over 1 round.

Here is the list of recent funding rounds of Shanghai Bima Life Sciences:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 19, 2024	5808107	Angel	1055920	2022286	7935821	7958244

Access funding benchmarks and valuations. Sign up today!

View details of Shanghai Bima Life Sciences's funding rounds and investors

The founders of Shanghai Bima Life Sciences is Wu Di.

Here are the details of Shanghai Bima Life Sciences' key team members:

Wu Di: Founder of Shanghai Bima Life Sciences.

View details of Shanghai Bima Life Sciences's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Shanghai Bima Life Sciences include Imperagen, Anzen Industries and DirectBio. Here is the list of Top 10 competitors of Shanghai Bima Life Sciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Imperagen 2021, Manchester (United Kingdom), Seed	Developer of enzyme engineering platform for drug development	$11.4M	IQ Capital, PXN Ventures & 1 others	51/100
2nd	Anzen Industries 2017, San Francisco (United States), Seed	Developer of technology to stabilize enzymes for chemical production outside cells	$2.2M	LocalGlobe, Creator Fund & 2 others	36/100
3rd	Shanghai Bima Life Sciences Seed	Provider of proteomics detection platform based on antibody affinity assay	-	-	24/100
4th	DirectBio 2023, San Francisco (United States), Unfunded	Provider of diagnostic assays utilizing AI-engineered CRISPR enzymes	-	-	15/100